133 related articles for article (PubMed ID: 6154663)
1. Establishment in continuous culture of a T-lymphoid cell line (HD-Mar) from a patient with Hodgkin's lymphoma.
Ben-Bassat H; Mitrani-Rosenbaum S; Gamliel H; Naparstek E; Leizerowitz R; Korkesh A; Sagi M; Voss R; Kohn G; Polliack A
Int J Cancer; 1980 May; 25(5):583-90. PubMed ID: 6154663
[TBL] [Abstract][Full Text] [Related]
2. Establishment of the Amsalem T-cell line from a patient with acute lymphoblastic leukemia. Expression of E-receptor-associated antigens in cells incapable of forming E-rosettes.
Ben Bassat H; Rabinowitz R; Polliack A; Hadar R; Schlesinger M
Int J Cancer; 1985 Jan; 35(1):27-33. PubMed ID: 2981779
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patient.
Gallmeier WM; Boecker WR; Bruntsch U; Hossfeld DK; Schmidt CG
Haematol Blood Transfus; 1977; 20():277-81. PubMed ID: 204548
[No Abstract] [Full Text] [Related]
4. Cultural, morphological, cell membrane, enzymatic, and neoplastic properties of cell lines derived from a Hodgkin's disease lymph node.
Roberts AN; Smith KL; Dowell BL; Hubbard AK
Cancer Res; 1978 Sep; 38(9):3033-43. PubMed ID: 209894
[TBL] [Abstract][Full Text] [Related]
5. Terminal deoxynucleotidyl transferase activity in lymphoma.
Habeshaw JA; Catley PF; Stansfield AG; Ganeshaguru K; Hoffbrand AV
Br J Cancer; 1979 May; 39(5):566-9. PubMed ID: 314814
[TBL] [Abstract][Full Text] [Related]
6. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
[TBL] [Abstract][Full Text] [Related]
7. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
9. Two E-rosette-forming lymphoid cell lines.
Morikawa S; Tatsumi E; Baba M; Harada T; Yasuhira K
Int J Cancer; 1978 Feb; 21(2):166-70. PubMed ID: 203546
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
11. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines.
Sundström C; Nilsson K
Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):173-84. PubMed ID: 211794
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus susceptibility of B cells correlates to the presence of complement receptors but not surface immunoglobulins.
Takada K; Osato T
Intervirology; 1981; 16(2):118-22. PubMed ID: 6276327
[TBL] [Abstract][Full Text] [Related]
13. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
14. Two neoplastic cell lines with unique features derived from Hodgkin's disease.
Schaadt M; Diehl V; Stein H; Fonatsch C; Kirchner HH
Int J Cancer; 1980 Dec; 26(6):723-31. PubMed ID: 7216541
[TBL] [Abstract][Full Text] [Related]
15. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
[TBL] [Abstract][Full Text] [Related]
16. Observations on cell lines derived from a patient with Hodgkin's disease.
Friend C; Marovitz W; Henie G; Henie W; Tsuei D; Hirschhorn K; Holland JG; Cuttner J
Cancer Res; 1978 Aug; 38(8):2581-91. PubMed ID: 78764
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a human null-cell lymphoblastic lymphoma cell line (K-LL-3).
Smith SD; Rosen D
Int J Cancer; 1979 Apr; 23(4):494-503. PubMed ID: 220200
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of a virus producing line established from a patient with leukaemia/lymphoma: comparison with T-lymphoblastic and myeloblastic lines.
Karpas A; Worman CP; Khalid G; Neumann H; Hayhoe FG; Newell D; Stewart JW
Br J Haematol; 1980 Mar; 44(3):415-24. PubMed ID: 6966506
[TBL] [Abstract][Full Text] [Related]
19. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
Lewis RE; Johnson WW; Cruse JM
Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
[No Abstract] [Full Text] [Related]
20. Critical evaluation of B and T cell markers in man.
Preud'Homme JL; Seligmann M
Rheumatology; 1975; 6():178-89. PubMed ID: 53874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
